CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):294-296. Published online 2018 September 11 DOI: https://doi.org/10.3350/cmh.2018.1009

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Jong Eun Yeon

Clinical and Molecular Hepatology. 2018;24(3):294-296

Link1

Link2 Link3

Comparison of Sofosbuvir Plus Ribavirin Plus Peg-Interferon With Sofosbuvir and Ribavirin for Treatment of Genotype 3 Treatment Naive Indian Chronic Hepatitis C Patients: An Interim Analysis of Ongoing RCT

Ujjwal Sonika

Journal of Clinical and Experimental Hepatology. 2016;6:S14

Link1 Link2

Dual Treatment With Sofosbuvir Plus Ribavirin is as Effective as Triple Therapy With Pegylated Interferon Plus Sofosbuvir Plus Ribavirin in Predominant Genotype 3 Patients With Chronic Hepatitis C

Sandeep Satsangi, Manu Mehta, Ajay Duseja, Sunil Taneja, Radha K. Dhiman, Yogesh Chawla

Journal of Clinical and Experimental Hepatology. 2016;6:S21

Link1 Link2

Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C

Sandeep Satsangi, Manu Mehta, Ajay Duseja, Sunil Taneja, Radha K Dhiman, Yogesh Chawla

Journal of Gastroenterology and Hepatology. 2017;32(4):859-863

Link1 Link2 Link3

Sofosbuvir plus ribavirin in Asian patients with chronic genotype 2 hepatitis C virus infection: history of a success?

Federico Sáez-Royuela, Ester Badia

Liver International. 2016;36(8):1093-1095

Link1 Link2 Link3

Su1452 Treatment of Chronic Hepatitis C Genotype 2 With Simeprivir Plus Sofosbuvir With or Without Ribavirin in Veterans With and Without Cirrhosis

Jennifer Haglund, Diane Ellis, Joseph Awad

Gastroenterology. 2016;150(4):S1104

Link1 Link2

Sofosbuvir/Velpatasvir plus Ribavirin for chronic hepatitis C virus genotype 3 infected cirrhotic patients with or without HIV or HBV coinfection: Real-world experience from Southwest China

Yongrui Yang, Ti Wu, Nihong Lu, Kang Huang, Zhirong Zhao, Haiwen Li, Yingrong Du

. 2023;

Link1 Link2

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2

Kayo Seo, Soo Ki Kim, Soo Ryang Kim, Aya Ohtani, Mana Kobayashi, Airi Kato, Eri Morimoto, Yuka Saijo, Ke Ih Kim, Susumu Imoto, Chi Wan Kim, Yoshihiko Yano, Masatoshi Kudo, Yoshitake Hayashi

Digestive Diseases. 2017;35(6):541-547

Link1 Link2

Does Ribavirin Still Have a Role in Sofosbuvir and Velpatasvir Therapy for Patients With HCV Genotype 3 Infection and Cirrhosis?

Ira M. Jacobson

Gastroenterology. 2018;155(4):969-971

Link1 Link2

P1-092: The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination

Journal of Viral Hepatitis. 2018;25:71-71

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.